MedPath
TGA Approval

TRELEGY ELLIPTA 200/62.5/25 fluticasone furoate 200 ug / umeclidinium (as bromide) 62.5 ug / vilanterol (as trifenatate) 25 ug powder for inhalation (335858)

335858

TRELEGY ELLIPTA 200/62.5/25 fluticasone furoate 200 ug / umeclidinium (as bromide) 62.5 ug / vilanterol (as trifenatate) 25 ug powder for inhalation

GlaxoSmithKline Australia Pty Ltd

May 10, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/871d80765a256698e99034c58627f8c3.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/38e045d3642b9437be348e5ee16d836c.pdf

Active Ingredients

fluticasone furoate

umeclidinium bromide

vilanterol trifenatate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRELEGY ELLIPTA 200/62.5/25 fluticasone furoate 200 ug / umeclidinium (as bromide) 62.5 ug / vilanterol (as trifenatate) 25 ug powder for inhalation (335858) - TGA 批准文号 | MedPath